Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Maximising the potential of AI in pharma

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved communities more quickly

- PMLiVE

Local muscle, global impact

Why local market input is the early commercialisation superpower

- PMLiVE

Driving Impact in Diabetes Care: Medscape to Present 11 Publications at ADA’s 85th Scientific Sessions

Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago. These presentations reflect our commitment to advancing diabetes care...

Medscape Education

- PMLiVE

Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition

The deal will give Lilly access to Verve’s pipeline of gene editing medicines for atherosclerotic CVD

- PMLiVE

AstraZeneca’s Ultomiris shows promise in rare post-transplant complication

There are currently no approved treatment options for HSCT-TMA

- PMLiVE

FDA unveils new voucher programme to accelerate drug review process

The programme is designed to reduce the review time for companies supporting US national interests

- PMLiVE

Achieving gender parity – designing clinical trials with women in mind

The importance of putting flexibility at the core of trials to make them more accessible for women

- PMLiVE

GDPR and events: what the pharma industry needs to know in 2025

In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to applying GDPR principles at events and tradeshows. With...

Apex Events and Exhibitions

- PMLiVE

Using technology to make your exhibitions stand out in 2025

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement tactics. Exhibitions remain one of the most effective marketing channels for the pharmaceutical...

Apex Events and Exhibitions

- PMLiVE

Roche to advance Parkinson’s disease candidate into phase 3 development

More than ten million people worldwide are living with the neurodegenerative disorder

- PMLiVE

Novartis shares positive late-stage results for Fabhalta in rare blood disorder PNH

Paroxysmal nocturnal haemoglobinuria affects approximately ten to 20 people per million worldwide

- PMLiVE

FDA approves new presentation of Celltrion’s SteQeyma for paediatric psoriasis

The Stelara biosimilar now offers all dosage forms and strengths of its reference product

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links